Found 7 matching trials
Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004) PHASE2 The purpose of this study is to assess the efficacy and safety of vintafoli...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) PHASE2 This is a Phase II clinical trial evaluating the benefit from therapy with ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) PHASE2 This is a Phase II clinical trial evaluating the benefit from therapy with ...
Show More Location
Multiple Locations
Learn More & Join Trial
Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) PHASE2 The objective of this study is to compare progression-free survival (PFS), ...
Show More Location
Multiple Locations
Learn More & Join Trial
Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010) PHASE2 This extension protocol is for those subjects that have completed the allow...
Show More Location
Center for Blood and Cancer Disorders
Learn More & Join Trial
Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) PHASE1 This is a Phase I clinical trial evaluating the safety and tolerability of ...
Show More Location
Greenebaum Cancer Center at University of Maryland Medical Center
Learn More & Join Trial
Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer PHASE2 This study will test the activity of single-agent EC145 and the combination...
Show More Location
Multiple Locations
Learn More & Join Trial